Share Article

"We are very thankful for the advice and expertise provided by SC&H Capital during the entire acquisition process," said Mark Feinberg, Managing Partner of Blue Jay Consulting.

Baltimore, MD (PRWEB)October 27, 2015

SC&H Capital, a leading investment banking and advisory firm focused on middle market and growth companies, served as the exclusive financial advisor to Blue Jay Consulting, LLC in its acquisition by Royal Philips (NYSE: PHG, AEX:PHIA).

Headquartered in Orlando, FL, Blue Jay Consulting is a leading provider of consulting services to hospital emergency departments in the U.S. The company has built a highly successful consulting practice offering their clients a comprehensive suite of outcome-oriented solutions including performance assessment, process improvement, interim staffing and coaching services.

Philips announced on October 6, 2015, that the acquisition will strengthen its healthcare consulting services in the U.S. Following the closing, Blue Jay Consulting will become part of Philips' Healthcare Informatics, Solutions and Services business, which offers hospitals and health systems leading consulting, education and design services, customized clinical programs, advanced data analytics, and interoperable cloud-based platforms necessary to implement new models of care.

“We are excited to join the Philips team and the opportunity to significantly expand upon Blue Jay’s offerings to new hospital clients across the U.S. and around the world," said Mark Feinberg, Managing Partner of Blue Jay Consulting. "We are very thankful for the advice and expertise provided by SC&H Capital during the entire acquisition process. Greg Hogan and his team provided us with the guidance we needed to reach a successful transaction for Blue Jay Consulting, our clients, and our employees."

“Blue Jay Consulting is the premier emergency department consulting firm in the U.S. and this transaction will allow the Company to build upon its success to date,” said Greg Hogan, Principal with SC&H Capital. “This acquisition is clearly a ‘win-win’ for both companies and the hospitals and patients that they serve.”

Financial terms of the deal were not disclosed. The Company was represented by Drinker Biddle & Reath LLP.